【ChiCTR2200057463】Effect of prehabilitation-related dietary protein intake on quality of recovery after elective cardiac surgery: a randomized controlled trial
ChiCTR2200057463
正在进行
/
/
/
2022-03-13
/
/
preoperative protein-calorie malnutrition
Effect of prehabilitation-related dietary protein intake on quality of recovery after elective cardiac surgery: a randomized controlled trial
Effect of prehabilitation-related dietary protein intake on quality of recovery after elective cardiac surgery: a randomized controlled trial
1. To determine the potential for dietitian guided change in preoperative dietary protein intake levels in malnourished patients scheduled for elective cardiac surgery undergoing nutritional prehabilitation. 2. To evaluate the effect of high-quality dietary protein intake on the quality of recovery after elective cardiac surgery in malnourished patients undergoing nutritional prehabilitation. 3. To evaluate the effect of nutritional prehabilitation on the length of postoperative stay in malnourished patients undergoing elective cardiac surgery. 4. To determine the synergistic effect of preoperative dietary protein intake and physical activity on quality of recovery after elective cardiac surgery in malnourished patients undergoing nutritional prehabilitation.
随机平行对照
Ⅳ期
This is a single-center, pragmatic, two-armed, parallel, superiority, blinded randomized controlled trial. Participants will be randomly allocated to either nutritional prehabilitation or usual care (no nutritional prehabilitation) with 1:1 allocation. Block randomization with randomly selected block sizes will be performed.
Due to the nature of the intervention and requirements of informed consent, trial participants were not blinded to the treatment allocation. Study research personnel who collected the follow-up nutritional status and food frequency intake at hospital admission were blinded from the treatment allocation. Outcome assessors were also blinded to the participant’s group allocation.
department funding
/
66
/
2022-09-01
2025-08-30
/
1. Adults (no age restriction) undergoing elective or non-emergent major to ultra-major cardiac surgery (CABG, valve surgery or combined) 2. MUST>0 or FFMI<17 for men or FFMI<15 for women or SMI<7 for men or SMI<5.7 for women Patients on the elective cardiac surgery waiting list are routinely assessed the Perioperative Medicine Clinic several weeks before the scheduled operation date. After written informed consent, patients will complete the MUST questionnaire and undertake a body composition test using a bioelectrical impedance analysis device (InBody 270, InBodyUSA, Cerritos, CA) to measure FFMI and SMI for study eligibility determination.；
请登录查看1. Redo or emergency cardiac surgery 2. Major comorbidities precluding surgery, are mentally incompetent, any current disorder impairing accurate and objective completion of the malnutrition assessment and questionnaires, or are unable to understand Chinese or English. 3. CKD not on dialysis requiring low protein diet, advanced stage CKD or end-stage renal disease on dialysis with protein requirements of 1.0 to 1.2 g/kg body weight/day will be excluded [38] 4. Patients with liver diseases and at risk for hepatic encephalopathy 5. Physical limitations that would preclude regular attendance to outpatient nutritional prehabilitation sessions 6. Seen by a dietician in the last 6 months；
请登录查看Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong
/
Department of Anesthesia and Intensive Care, The Chinese University of Hong Kong的其他临床试验
- Effect of prehabilitation-related dietary protein intake on quality of recovery after elective cardiac surgery: a randomized controlled trial
- Effect of a patient education video and prehabilitation on the quality of preoperative person-centred coordinated care experience: a randomized controlled trial
香港中文大學的其他临床试验
- 治療無視野缺損性正常眼壓性青光眼（PNTG）的生活品質、療效和安全性:一項多中心隨機對照試驗
- Feasibility, Acceptability and Effectiveness of a Tailored Multidimensional Intervention for Dementia Family Caregivers in Caregiving and Mental Health Crisis: A Pilot Randomised Controlled Trial
- One-step Rehydration Thawing Method in Frozen Embryo Transfer: A pragmatic randomized controlled clinical trial (ORT-FET-RCT)
- 以環孢素眼藥水作為一線治療「非乾燥症而血清因子陽性的水液缺乏型乾眼症」的多中心隨機對照試驗
- 動作協調障礙兒童體育課中的內隱動作學習
- Building Resilience Against Rising Temperature - The Effect of High-Intensity Interval Exercise (HIIE) on Heat Tolerance, Thermoregulatory Adaptation, and Physical Fitness: A Comparative Randomized Controlled Trial
- 一項前瞻性、單組介入研究：評估不含防腐劑交聯透明質酸和蘆薈眼藥水於白內障術後乾眼的療效
- 运动与脑刺激疗愈：促进居住于分间楼宇单位的注意力缺陷多动障碍儿童症状控制的三臂随机对照试验
- Effects of Care partner Online Programme for Managing BPSD and Enhancing Wellbeing (COPE‑BPSD)
- 混合實境及沉浸式的神經認知眼科診斷 (MIND) 平台
- Air purifier and respiratory outcomes in childhood asthma in compromised housing environments: a hybrid effectiveness-implementation trial
- 青光眼中圖樣視網膜電圖之結構與功能整合
- 一种用于糖尿病视网膜病变定量病灶评估的眼动追踪注意感知强化学习算法
- 甲狀腺眼病患者外周免疫細胞譜
- Young Adult Community Health Advisor (YACHA)-led Project to Promote Anti-drug Awareness among South Asian Youths and their Family in Hong Kong
- 瞼板腺功能障礙的代謝組學研究
- Dissecting the role of gut microbiota in primary glaucoma patients through case-control and longitudinal cohort study
- 以理論為基礎的跨專業教育計劃，以提高香港華人社區長者的新冠疫苗接種率
- 復發性眼部單純疱疹病毒疾病患者的生活質素與病人自述結果：一項前瞻性橫斷面研究
- 正常眼壓青光眼疑似個案及視野缺損早期患者之眼壓藥物調整研究
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04